| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1021/CR200008N |
| P698 | PubMed publication ID | 21663322 |
| P50 | author | Ferid Murad | Q295999 |
| P2093 | author name string | Alexander M Seifalian | |
| Achala de Mel | |||
| P2860 | cites work | Red blood cells express a functional endothelial nitric oxide synthase | Q22299208 |
| Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells | Q24295227 | ||
| Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways | Q24322688 | ||
| S-nitrosylation in cardiovascular signaling | Q24630263 | ||
| NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | Q24656131 | ||
| Endogenous S-nitrosothiols protect against myocardial injury | Q24658413 | ||
| NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism | Q27641107 | ||
| Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase | Q27661554 | ||
| Heme-dependent and independent soluble guanylate cyclase activators and vasodilation. | Q27692662 | ||
| Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting | Q28194402 | ||
| Scientific and therapeutic advances in antiplatelet therapy | Q28194547 | ||
| Protective role of endothelial nitric oxide synthase | Q28217045 | ||
| A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease | Q28238811 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase | Q28369918 | ||
| Resistance to nitric oxide-induced necrosis in heme oxygenase-1 overexpressing pulmonary epithelial cells associated with decreased lipid peroxidation | Q28581214 | ||
| Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization | Q28609898 | ||
| The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
| Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase | Q30309271 | ||
| Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations | Q30449094 | ||
| Improving the patency of vascular bypass grafts: the role of suture materials and surgical techniques on reducing anastomotic compliance mismatch | Q30902083 | ||
| Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data | Q31149143 | ||
| Unraveling peroxynitrite formation in biological systems. | Q31969110 | ||
| NO-independent regulatory site on soluble guanylate cyclase | Q32165040 | ||
| Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. | Q51006216 | ||
| Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications. | Q51321853 | ||
| Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. | Q51355810 | ||
| When metabolism rules perfusion: AMPK-mediated endothelial nitric oxide synthase activation. | Q51796605 | ||
| Regulation of xanthine oxidase by nitric oxide and peroxynitrite. | Q52538534 | ||
| Haemodynamic regulation of gene expression in vascular tissue engineering. | Q53321608 | ||
| Inhibition of ADP-induced platelet adhesion to immobilised fibrinogen by nitric oxide: Evidence for cGMP-independent mechanisms | Q57393650 | ||
| cGMP-independent inhibition of integrin αIIbβ3-mediated platelet adhesion and outside-in signalling by nitric oxide | Q57393651 | ||
| Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial | Q57951501 | ||
| Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells | Q58816342 | ||
| S-Nitrosylation of Platelet αIIbβ3As Revealed by Raman Spectroscopy† | Q59659533 | ||
| Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium | Q69908131 | ||
| Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting | Q73033329 | ||
| Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress | Q79667081 | ||
| Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin | Q79985201 | ||
| (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm | Q80108377 | ||
| Impact of preoperative intravenous nitroglycerin on in-hospital outcomes after coronary artery bypass grafting for unstable angina | Q80810566 | ||
| Role of S-nitrosothiol transport in the cardioprotective effects of S-nitrosocysteine in rat hearts | Q80969152 | ||
| Discovery of some of the biological effects of nitric oxide and its role in cell signaling | Q81142829 | ||
| Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes | Q81411477 | ||
| Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia | Q83214945 | ||
| Nitric oxide is an essential mediator of the protective effects of remote ischaemic preconditioning in a mouse model of liver ischaemia/reperfusion injury | Q83777965 | ||
| Role of endothelial nitric oxide synthase in remote ischemic preconditioning of the mouse liver | Q83908906 | ||
| The "no-touch" harvesting technique for vein grafts in coronary artery bypass surgery preserves an intact vasa vasorum | Q84035479 | ||
| Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase | Q84320236 | ||
| Endothelial integrity of radial artery grafts harvested by minimally invasive surgery--immunohistochemical studies of CD31 and endothelial nitric oxide synthase expressions: a randomized controlled trial | Q85048698 | ||
| Nitrite-induced improved blood circulation associated with an increase in a pool of RBC-NO with no bioactivity | Q37148270 | ||
| Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells | Q37176379 | ||
| SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation | Q37236843 | ||
| Nitroxyl (HNO): the Cinderella of the nitric oxide story | Q37286469 | ||
| A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis | Q46564589 | ||
| Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction | Q46752447 | ||
| Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins | Q46755509 | ||
| Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery | Q46914031 | ||
| Inhibition of clotting factor XIII activity by nitric oxide | Q47680139 | ||
| The ligand binding battle at cytochrome c oxidase: how NO regulates oxygen gradients in tissue | Q47747644 | ||
| Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity | Q47845748 | ||
| Regulation of oxygen distribution in tissues by endothelial nitric oxide | Q47905061 | ||
| Tissue engineering of a hybrid bypass graft for coronary and lower limb bypass surgery | Q47970429 | ||
| In vivo femoropopliteal arterial wall compliance in subjects with and without lower limb vascular disease. | Q49072652 | ||
| Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. | Q50753944 | ||
| Development of cardiovascular bypass grafts: endothelialization and applications of nanotechnology | Q37304690 | ||
| Nucleotide regulation of soluble guanylate cyclase substrate specificity | Q37342409 | ||
| Biochemistry of soluble guanylate cyclase | Q37352750 | ||
| NO- and haem-independent soluble guanylate cyclase activators | Q37352787 | ||
| Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort | Q37359838 | ||
| Mechanisms of activity-dependent plasticity in cellular nitric oxide-cGMP signaling | Q37377637 | ||
| Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition | Q37390548 | ||
| Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. | Q37391969 | ||
| Cardioprotection: a radical view Free radicals in pre and postconditioning | Q37402889 | ||
| Shear stress inhibits homocysteine-induced stromal cell-derived factor-1 expression in endothelial cells | Q37407437 | ||
| C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling | Q37408109 | ||
| Cardiovascular consequences when nitric oxide and lipid signaling converge | Q37412845 | ||
| Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus | Q37412979 | ||
| Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production | Q37467533 | ||
| A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase | Q37467778 | ||
| Nitroxyl (HNO) signaling | Q37524902 | ||
| Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. | Q37588350 | ||
| Comparing the chemical biology of NO and HNO. | Q37591261 | ||
| Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation | Q37603613 | ||
| Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion | Q37637606 | ||
| New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications | Q37655398 | ||
| NO synthase: structures and mechanisms | Q37715170 | ||
| Thromboelastographic study of biomaterials. | Q37768388 | ||
| The potential role of the red blood cell in nitrite-dependent regulation of blood flow. | Q37800751 | ||
| The implications of human stem cell differentiation to endothelial cell via fluid shear stress in cardiovascular regenerative medicine: a review | Q37815516 | ||
| In situ endothelialization of intravascular stents from progenitor stem cells coated with nanocomposite and functionalized biomolecules | Q37859059 | ||
| How safe and how good are drug-eluting stents? | Q37859760 | ||
| Synthesis of adenosine 3′,5′-monophosphate by guanylate cyclase, a new pathway for its formation | Q39273811 | ||
| Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury | Q39691556 | ||
| Thrombosis: the last frontier of coronary stenting? | Q39787837 | ||
| Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation | Q39847509 | ||
| Arginase inhibition mediates cardioprotection during ischaemia-reperfusion | Q39949897 | ||
| Drug-eluting stents: beyond the hyperbole | Q40335955 | ||
| Soluble guanylate cyclase is activated differently by excess NO and by YC-1: resonance Raman spectroscopic evidence | Q40978111 | ||
| Probing soluble guanylate cyclase activation by CO and YC-1 using resonance Raman spectroscopy | Q41563697 | ||
| Vitreous cryopreservation maintains the viscoelastic property of human vascular grafts | Q41613617 | ||
| Erythrocytes possess an intrinsic barrier to nitric oxide consumption. | Q41715696 | ||
| The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols. | Q41909315 | ||
| Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity. | Q42439086 | ||
| Formation and role of plasma S-nitrosothiols in liver ischemia-reperfusion injury | Q33275369 | ||
| Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. | Q33420176 | ||
| Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation | Q33504506 | ||
| Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression | Q33512668 | ||
| Oxygen regulates the effective diffusion distance of nitric oxide in the aortic wall | Q33640643 | ||
| Generic nitric oxide (NO) generating surface by immobilizing organoselenium species via layer-by-layer assembly | Q33666779 | ||
| Nitrate and nitrite in biology, nutrition and therapeutics | Q33685139 | ||
| Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase | Q33772904 | ||
| Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall | Q33775475 | ||
| Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS | Q33788731 | ||
| Incorporation of tyrosine and glutamine residues into the soluble guanylate cyclase heme distal pocket alters NO and O2 binding | Q33885131 | ||
| Regulation of platelet granule exocytosis by S-nitrosylation | Q33928520 | ||
| Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP | Q33948069 | ||
| The NO cascade, eNOS location, and microvascular permeability | Q33954970 | ||
| Nitric oxide donors: chemical activities and biological applications | Q33958494 | ||
| Non-heme iron nitrosyls in biology | Q33958501 | ||
| S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood | Q34007606 | ||
| Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-beta pathway | Q34075605 | ||
| Soluble guanylate cyclase agonists inhibit expression and procoagulant activity of tissue factor | Q34122462 | ||
| Point-of-care testing in haemostasis | Q34125183 | ||
| Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. | Q34190234 | ||
| The mechanical behavior of vascular grafts: a review | Q34191346 | ||
| Nitric oxide insufficiency, platelet activation, and arterial thrombosis | Q34234301 | ||
| cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action | Q34244951 | ||
| Neuronal nitric oxide synthase and human vascular regulation | Q34322415 | ||
| Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration | Q34480130 | ||
| Nitric oxide and myoglobins | Q34593744 | ||
| Intrinsic and extrinsic modulation of nitric oxide synthase activity. | Q34593750 | ||
| Mechanism of free-radical generation by nitric oxide synthase | Q34593757 | ||
| A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors | Q34657858 | ||
| Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review | Q34843553 | ||
| NO-independent, haem-dependent soluble guanylate cyclase stimulators | Q34906036 | ||
| Mechanical stimulation of nitric oxide synthesizing mechanisms in erythrocytes | Q34982220 | ||
| Nitrate tolerance: a unifying hypothesis | Q34989643 | ||
| Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension | Q42458586 | ||
| Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation | Q42461755 | ||
| Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model | Q42505263 | ||
| Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance | Q42544768 | ||
| Hemoglobin-based red blood cell substitutes and nitric oxide | Q42575895 | ||
| AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633 | Q42582636 | ||
| Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion. | Q42870186 | ||
| Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. | Q42949146 | ||
| H-NOX domains display different tunnel systems for ligand migration | Q43118394 | ||
| NO way to relax: the complexities of coupling nitric oxide synthase pathways in the heart | Q43190641 | ||
| Exogenous nitric oxide donation causes desensitization of arteriolar relaxing activity in vivo: an intravital analysis in mice | Q43200144 | ||
| Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury | Q43216284 | ||
| Regulation of arginase pathway in response to wall shear stress | Q43234150 | ||
| Degradation of leucine zipper-positive isoform of MYPT1 may contribute to development of nitrate tolerance | Q43235396 | ||
| Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain | Q43274543 | ||
| Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury | Q43295132 | ||
| L-arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation | Q43660940 | ||
| Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study | Q43727866 | ||
| Antimicrobial effects of an NO-releasing poly(ethylene vinylacetate) coating on soft-tissue implants in vitro and in a murine model | Q43729436 | ||
| Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment | Q43913687 | ||
| Analysis of nitric oxide consumption by erythrocytes in blood vessels using a distributed multicellular model | Q43979993 | ||
| The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver | Q44122089 | ||
| Coexistence of impairment of endothelium-derived nitric oxide and platelet-derived nitric oxide in patients with coronary risk factors | Q44133079 | ||
| Effect of folic acid on nitrate tolerance in healthy volunteers: differences between arterial and venous circulation | Q44291350 | ||
| The excitement and rewards of research with our discovery of some of the biological effects of nitric oxide | Q44353722 | ||
| Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). | Q44612612 | ||
| L-arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats | Q44623142 | ||
| L-arginine improves endothelial vasoreactivity and reduces thrombogenicity after thrombolysis in experimental deep venous thrombosis | Q44697507 | ||
| Rapid regulation of platelet activation in vivo by nitric oxide | Q44832212 | ||
| Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release | Q44891136 | ||
| Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response | Q45008791 | ||
| Inhibition of implant-associated infections via nitric oxide release | Q45035156 | ||
| Shear flow increases S-nitrosylation of proteins in endothelial cells | Q45324725 | ||
| The arachidonic acid effect on platelet nitric oxide level. | Q45926340 | ||
| Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite. | Q45933524 | ||
| Soluble guanylate cyclase: not a dull enzyme. | Q46006838 | ||
| BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts. | Q46029902 | ||
| Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity | Q46045587 | ||
| Design of recombinant hemoglobins for use in transfusion fluids | Q46063787 | ||
| Plasma tetrahydrobiopterin/dihydrobiopterin ratio: a possible marker of endothelial dysfunction | Q46085026 | ||
| Manufacture of small calibre quadruple lamina vascular bypass grafts using a novel automated extrusion-phase-inversion method and nanocomposite polymer | Q46105747 | ||
| Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production | Q46112203 | ||
| Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation | Q46113820 | ||
| A molecular basis for NO selectivity in soluble guanylate cyclase | Q46238227 | ||
| Nitric oxide specifically inhibits integrin-mediated platelet adhesion and spreading on collagen. | Q46265336 | ||
| Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study | Q46318694 | ||
| L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease | Q46320582 | ||
| Dynamical characterization of the heme NO oxygen binding (HNOX) domain. Insight into soluble guanylate cyclase allosteric transition | Q46430282 | ||
| Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver | Q46471344 | ||
| Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells | Q46535137 | ||
| Arterial elastic properties and cardiovascular risk/event | Q34999373 | ||
| Nitric oxide-releasing drugs | Q35050581 | ||
| Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention | Q35099318 | ||
| Tetrahydrobiopterin radical enzymology | Q35150179 | ||
| Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases | Q35192636 | ||
| Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review | Q35613990 | ||
| Chemistry of nitric oxide relevant to biology | Q35660847 | ||
| Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation | Q35925811 | ||
| Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. | Q36002621 | ||
| Chemistry of peroxynitrites as compared to peroxynitrates | Q36154656 | ||
| Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. | Q36182005 | ||
| Explaining the phenomenon of nitrate tolerance | Q36272905 | ||
| Understanding nitric oxide physiology in the heart: a nanomedical approach | Q36287357 | ||
| Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling | Q36384766 | ||
| Tissue engineering of blood vessels | Q36405174 | ||
| The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency | Q36412036 | ||
| The role of oxidants and free radicals in reperfusion injury | Q36437576 | ||
| Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia | Q36497132 | ||
| Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development | Q36648534 | ||
| Polyurethane with tethered copper(II)-cyclen complex: preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols | Q36691757 | ||
| Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review | Q36752743 | ||
| Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury | Q36786800 | ||
| Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences | Q36798691 | ||
| Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective | Q36801006 | ||
| The role of nitric oxide in the pathophysiology of intimal hyperplasia. | Q36837880 | ||
| Biochemistry of protein tyrosine nitration in cardiovascular pathology | Q36838128 | ||
| Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. | Q36842314 | ||
| Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction | Q36905844 | ||
| Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells | Q36943965 | ||
| Platelet-derived nitric oxide signaling and regulation. | Q36954134 | ||
| Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. | Q36999849 | ||
| The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics | Q37048314 | ||
| Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects | Q37087728 | ||
| Platelet hyperaggregability: impaired responsiveness to nitric oxide ("platelet NO resistance") as a therapeutic target | Q37104785 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 5742-5767 | |
| P577 | publication date | 2011-06-13 | |
| P1433 | published in | Chemical Reviews | Q900502 |
| P1476 | title | Nitric oxide: a guardian for vascular grafts? | |
| P478 | volume | 111 |
| Q28829091 | A Material Conferring Hemocompatibility |
| Q34097540 | A new era of cancer treatment: carbon nanotubes as drug delivery tools |
| Q39697934 | A novel method for the extraction and culture of progenitor stem cells from human peripheral blood for use in regenerative medicine. |
| Q51654975 | Alleviating effects of exogenous NO on tomato seedlings under combined Cu and Cd stress. |
| Q38095588 | Arterial tissue regeneration for pediatric applications: inspiration from up-to-date tissue-engineered vascular bypass grafts |
| Q39017881 | Biocatalytic polymer thin films: optimization of the multilayered architecture towards in situ synthesis of anti-proliferative drugs |
| Q34795651 | Biocompatibility and favorable response of mesenchymal stem cells on fibronectin-gold nanocomposites |
| Q39331783 | Biofabrication and biomaterials for urinary tract reconstruction |
| Q33660457 | Biomaterials in cardiovascular research: applications and clinical implications. |
| Q39165018 | Cardiovascular Bio-Engineering: Current State of the Art. |
| Q90603814 | Controlled Delivery of Nitric Oxide for Cancer Therapy |
| Q48312369 | Convergent synthesis and properties of photoactivable NADPH mimics targeting nitric oxide synthases. |
| Q39301982 | Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitors |
| Q50258998 | Dual-acting biofunctionalised scaffolds for applications in regenerative medicine. |
| Q55338911 | Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide. |
| Q51608477 | Evaluation of experimental methods for nitric oxide release from cardiovascular implants; bypass grafts as an exemplar. |
| Q92760406 | From surface to bulk modification: Plasma polymerization of amine-bearing coating by synergic strategy of biomolecule grafting and nitric oxide loading |
| Q45885399 | Fumed silica nanoparticle mediated biomimicry for optimal cell-material interactions for artificial organ development |
| Q35821076 | Functionalization of single-walled carbon nanotubes and their binding to cancer cells. |
| Q38844730 | Heteropentanuclear Oxalato-Bridged nd-4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis, Crystal Structures, Aqueous Stability and Antiproliferative Activity |
| Q38605831 | In situ Endothelialization: Bioengineering Considerations to Translation. |
| Q45997487 | In vitro endothelialization of cobalt chromium alloys with micro/nanostructures using adipose-derived stem cells. |
| Q37100376 | Influence of chirality on catalytic generation of nitric oxide and platelet behavior on selenocystine immobilized TiO2 films |
| Q94673509 | Layer-by-layer deposition of bioactive layers on magnesium alloy stent materials to improve corrosion resistance and biocompatibility |
| Q53610441 | Lipophilic ruthenium salen complexes: incorporation into liposome bilayers and photoinduced release of nitric oxide. |
| Q50888199 | Mechanical Adaptability of the MMP-Responsive Film Improves the Functionality of Endothelial Cell Monolayer. |
| Q97526382 | Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis |
| Q33651014 | Nitric oxide generation from heme/copper assembly mediated nitrite reductase activity |
| Q38842183 | Nitric oxide in paediatric respiratory disorders: novel interventions to address associated vascular phenomena? |
| Q53662133 | Nitric oxide-eluting nanocomposite for cardiovascular implants. |
| Q51358082 | Nitric oxide-generating l-cysteine-grafted graphene film as a blood-contacting biomaterial. |
| Q38025039 | Orchestrating cell/material interactions for tissue engineering of surgical implants |
| Q55285400 | Progress and Promise of Nitric Oxide-Releasing Platforms. |
| Q36423922 | Recent Advances in Multinuclear Metal Nitrosyl Complexes |
| Q54985958 | Selective and sensitive visualization of endogenous nitric oxide in living cells and animals by a Si-rhodamine deoxylactam-based near-infrared fluorescent probe. |
| Q27005572 | Stem cell tracking using iron oxide nanoparticles |
| Q30623124 | Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles |
| Q37258891 | Substrate Stiffness Combined with Hepatocyte Growth Factor Modulates Endothelial Cell Behavior. |
| Q28728811 | Surface modification of biomaterials: a quest for blood compatibility |
| Q49338890 | The Preparation, Structural Characteristics, and Physical Chemical Properties of Metal-Nitrosyl Complexes. |
| Q61966357 | Tracing the Iron Nitrosyl Complex [Fe(2,2′-bipyridine)(CN)3(NO)]- |
Search more.